Table 3. Probability of PDAC based on a combination of significant biomarkers.
uMMP-2 (⩾1.1 ng ml–1) | uTIMP-1 (⩾0.9 ng ml–1) | Probability of PDAC | 95% CI |
---|---|---|---|
No | No | 8% | 3–18% |
Yes | No | 35% | 13–60% |
No | Yes | 50% | 32–67% |
Yes | Yes | 85% | 72–93% |
Abbreviations: CI=confidence interval; PDAC=pancreatic ductal adenocarcinoma; uMMP-2=urinary matrix metalloprotease-2; uTIMP-1= urinary tissue inhibitor of metalloprotease-1.